Latest filing published 04 May 2023 for GeneDx Holdings Corp..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Daniel Emmett Clark: trading record in brief
Daniel Emmett Clark is a declared insider of GeneDx Holdings Corp. (board member), with filings sourced from SEC (Form 4). Between 25 October 2021 and 26 July 2022, the trades on record add up to 13 filings.
No open-market purchase appears, only 5 sales worth €18k. The rest of the record consists of 2 share grants and 6 option exercises. 2023 to date brings no purchases and 1 sale.
The record was last updated on 4 May 2023 with an open-market sale (€1,553) in GeneDx Holdings Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel Emmett Clark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,005 sharesClass A Common StockSEC:0001209191-23-027546:0
- 3,940 sharesClass A Common StockSEC:0001209191-22-043281:0
- 1,212 shares@ US$2.18043.4% of flowClass A Common StockSEC:0001209191-22-026492:0
- 3,940 sharesClass A Common StockSEC:0001209191-22-025889:0
- 1,512 shares@ US$2.84235.2% of flowClass A Common StockSEC:0001209191-22-006608:0
- 3,940 sharesClass A Common StockSEC:0001209191-22-005283:0
- 275,000 shares@ US$0.152949.6% of flowClass A Common StockSEC:0001209191-22-003867:0
- 5,800 shares@ US$6.0541.8% of flowClass A Common StockSEC:0001209191-21-067984:0
- 3,940 sharesClass A Common StockSEC:0001209191-21-062546:0
9 of 9 declarations
